Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.000001 GBP per share
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
8.4K
-
Shares change
-
+8.4K
-
Total reported value, excl. options
-
$55.8K
-
Value change
-
+$55.8K
-
Number of buys
-
4
-
Price
-
$6.65
Significant Holders of Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.000001 GBP per share (BDRX) as of Q3 2025
4 filings reported holding BDRX - Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.000001 GBP per share as of Q3 2025.
Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.000001 GBP per share (BDRX) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.4K shares
.
Largest 4 shareholders include UBS Group AG (6.93K shares), GAMMA Investing LLC (1.35K shares), SBI Securities Co., Ltd. (115 shares), and RHUMBLINE ADVISERS (5 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.